The case of pharmacist prescribing policy in Israel

Israel Journal of Health Policy Research

Volumn 4, Issue 1, 2015, Pages

  Yariv, Hila ^a  

^a Pozna School of Economics   (Poland)

Author keywords

Institutions; Israel; Pharmaceutical governance; Pharmaceutical policy; Pharmacist prescribing; Stakeholders

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; CANADA; CONSULTATION; DRUG FORMULARY; DRUG INDUSTRY; DRUG LEGISLATION; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HEALTH ECONOMICS; HUMAN; INTERPERSONAL COMMUNICATION; ISRAEL; MEDICAL SOCIETY; PHARMACIST; PHARMACY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PUBLIC HEALTH SERVICE; STAKEHOLDER; WORLD HEALTH ORGANIZATION;

EID: 84949677394     PISSN: None     EISSN: 20454015     Source Type: Journal    
DOI: 10.1186/s13584-015-0045-4     Document Type: Article

References (100)

1. Savedoff WD. Governance in the health sector: a strategy for measuring determinants and performance. In: World Bank Policy Research Working Paper Series, Vol. 2001. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1837205. Accessed 8 September 2015.
2. Anello E. A framework for good governance in the public pharmaceutical sector, working draft for field testing and revision October 2008. WHO. 2008. http://www.who.int/medicines/areas/policy/goodgovernance/WHO-GGMframework.pdf. Accessed 04 January 2014
3. Lewis M, Pettersson G. Governance in health care delivery: raising performance. 2009. https://ideas.repec.org/p/wbk/wbrwps/5074.html.
4. UNESCAP: What is good governance? http://www.unescap.org/sites/default/files/good-governance.pdf. Accessed 20 July 2014.
5. Carrin G, Mathauer I, Xu K, Evans DB. Universal coverage of health services: tailoring its implementation. Bull World Health Organ. 2008;86(11):857-63.
6. Faden L, Wagner A. Active pharmaceutical management strategies of health insurance systems to improve cost effective use of medicines in low-and middle income countries: A systematic review of current evidence. Health Policy. 2011;100:134-43.
7. Ashton T, Mays N, Devlin N. Continuity through changes: the rhetoric and reality of health reform in New Zealand. Soc Sci Med. 2005;61:253-62.
8. Maddox C. Influences on non-medical prescribing: nurse and pharmacists prescribers in primary and community care. PhD thesis. Manchester University, Pharmacy and Pharmaceutical Science Department; 2011.
9. Feeney D. A comparative analysis of nurse practitioners with and without prescriptive authority. J Am Acad Nurse Pract. 2007;4(2):36-42.
10. Adamcik BA, Ransford HE, Oppenheimer PR, Brown JF, Eagan PA, Weissman FG. New clinical roles for pharmacists: a study of role expansion. Soc Sci Med. 1986;23(11):1187-200.
11. Rosen B. in Thomson S, Mossialos E, editors. Health care systems in transition: Israel. Copenhagen, European Observatory on Health Care Systems. 2003;5(1).
12. The Pharmaceutical Society of Israel. www.psi.org.il. Accessed 20 Feb 2014.
13. Reeves A, Stuckler D. Crowd-out of defence and health spending: is Israel different from other industrialised nations? Isr J Health Policy Res. 2013;2:14.
14. Pharmaceuticals and Healthcare Report - Israel Q4 2014. Business Monitor International. 2014. http://www.reportlinker.com/p0147978-summary/Israel-Pharmaceuticals-and-Healthcare-Report-Q4.html. Accessed 8 September 2015.
15. Hemmings P. How to improve Israel's health care system. ECO/WKP. 2014. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ECO/WKP%282014%2910&docLanguage=En. Accessed 16 November 2014.
16. Bystrov E, Soffer A. Israel, demography 2013-2034: challenges and chances. Haifa: University of Haifa - Chaikin Chair in Geostategy; 2013.
17. Epstein L, Goldway R, Ismail S, Greenstein M, Rosen B. Reducing health inequality and health inequity in Israel: towards a national policy and action program, The Smokler Center for Health Policy Research. Jerusalem: The Myers-JDC-Brookdale institute; 2006.
18. Bowers L. Hot issues in Israel's Healthcare system. Taub Center. 2014. http://taubcenter.org.il/wp-content/files_mf/htissues_taubcenter.org.il_tauborgilwp_wpcontent_uploads_e2014healthcarepolicybrief.pdf. Accessed 8 September 2015.
19. Deutsch J, Lazar A, Silber J. Becoming poor and the cutback in the demand for health services in Israel. Isr J Health Policy Res. 2013;2:49.
20. Degani A, Degani R. The impact of the economic burden on the consumption of health services in Israel. Survey of the Israeli medical association; 2009. http://www.ima.org.il/Ima/FormStorage/Type7/10EShivyon.pdf. Accessed 8 September 2015 in Hebrew Israel Medical Association.
21. Brammli-Greenberg S, Rosen B, Wood F. Households, health plans and expenditures for medication. Myers-JDC-Brookdale. 2003. http://brookdale.jdc.org.il/?CategoryID=192&ArticleID=191. Accessed 18 July 2014.
22. Brammli-Greenberg S, Gross R, Waitzberg R. Public opinion on the level of service performance of the health-care system in 2007 and in comparison with previous years. Myers-JDC-Brookdale. 2009. http://brookdale.jdc.org.il/?CategoryID=192&ArticleID=11. Accessed 18 July 2014.
23. Scott WR. Institutions and Organizations. CA: Sage Publications; 2001.
24. Schmeer K. Guidelines for conducting a stakeholder analysis, Health Reforms tools series. U.S.A: S PHR, Abt Associates; 1999.
25. Ruhe M. Stakeholder analysis in health services management. http://www.case.edu/med/epidbio/mphp439/Stakeholder_Analysis.htm. Accessed 5 November 2014.
26. Reed M, Graves A. Who's in and why? A typology of stakeholder analysis methods for natural resource management. J Environ Manage. 2009;90:1933-49.
27. Whitley E, Pouloudi A. Stakeholder identification in inter-organisational systems: gaining insights for drug use management systems. Eur J Inf Syst. 1997;6:1-14.
28. The National Nursing and Nursing Education Taskforce. Australian Health Ministry Advisory Council June 2006. http://www.nnnet.gov.au/downloads/n3et_national_nurse_prescribing_glossary.pdf. Accessed 15 Feburary 2014.
29. UpToDate. http://www.uptodate.com/contents/drug-prescribing-for-older-adults. Accessed 20 July 2015.
30. Morgan P, Taschereau S. Capacity and institutional assessment: frameworks, methods and tools for analysis. Canadian International Development Agency. June 1996. http://www.seesac.org/sasp2/english/publications/7/capacity/8.pdf. Accessed 14 July, 2014.
31. Brugha R, Varvasovszky Z. Stakeholder analysis: a review. Health Policy Plan. 2000;15(3):239-46.
32. Freeman R, Reed D. Stockholders and stakeholders: a new perspective on corporate governance. Calif Manage Rev. 1983;25:88-106.
33. Donaldson T, Preston LE. The Stakeholder Theory of the Corporation: Concepts, Evidence, and Implications. The Acad Manage Rev. 1995;20(1):65-91.
34. Phillips R. Stakeholder theory and organizational ethics. Berrett-Koehler Publishers; 2003. https://books.google.co.il/books?hl=iw&lr=&id=D4qvPUbZw5MC&oi=fnd&pg=PR3&dq=Phillips+R.+Stakeholder+theory+and+organizational+ethics.+Berrett-Koehler+Publishers%3B+2003.&ots=i02JKky6AY&sig=3GfQOHCZeddLLs1qD4g764Sdwnc&redir_esc=ynov=onepage&q&f=false. Accessed 8 September 2015.
35. North DC. The new institutional economics and development. In: Conference on Public Choice and Development: The New Institutional Economics and Third World Development: 16-18 September 1993; London.
36. Harvey J. A new institutional economics perspective on the relationship among societal values, governance structure and access to rural health care services. Working Papers 7362. University of Missouri Columbia, Department of Agricultural Economics; 2007. https://ideas.repec.org/p/ags/umcowp/7362.html. Accessed 8 September 2015.
37. Volkerink B, De Bas P, Van Gorp N, Philipsen N. Study of regulatory restrictions in the field of pharmacies. Report for the European Commission, Internal Market and Services DG. Rotterdam: ECORYS Nederland BV; 2007.
38. Hoti K, Hughes J. An expanded prescribing role for pharmacist - An Australian perspective. Australian Med J. 2011;4(4):236-42.
39. Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M, Gerard K, et al. Evaluation of nurse and pharmacist independent prescribing. Southampton: Keele University; 2010.
40. Davis LE, North DC, Smorodin C. Institutional Change and American Economic Growth. Cambridge: Cambridge University Press; 1971.
41. Roberts M, Reich MR. Pharmaceutical reform: a guide to improving performance and equity. The World Bank. 2011. https://openknowledge.worldbank.org/bitstream/handle/10986/2353/646660PUB0Phar00Box361543B00PUBLIC0.pdf?sequence=1. Accessed 8 September 2015.
42. Seiter A. A practical approach to Pharmaceutical Policy. The World Bank. 2010. https://openknowledge.worldbank.org/bitstream/handle/10986/2468/552030PUB0Phar10Box349442B01PUBLIC1.pdf?sequence=4. Accessed 16 August 2014.
43. Knesset website. https://www.knesset.gov.il/description/eng/eng_work_mel2.htm. Accessed 15 February 2014.
44. Kanavos P, Degnan D, Fortess E. Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector. In: Mossialos E, Mrazek M, Walley T, editors. Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Berkshire: McGraw-Hill International; 2004. p. 97-113.
45. The Israeli Medical Association. The joint ethics covenant, March 2014. http://www.pharma-israel.org.il/en/wp-content/uploads/2014/11/IMA_Amana-Pharma.English.pdf. Accessed 8 September 2015.
46. Schumock GT, Li EC, Suda KJ, Matusiak LM, Hunkler RJ, Vermeulen LC, et al. National trends in prescription drug expenditures and projections for 2014. Am J Health Syst Pharm. 2014;71(6):482-99.
47. NHSBSA. www.nhsbsa.nhs.uk. Accessed 5 July 2014.
48. Statista. http://www.statista.com/statistics/309387/global-total-prescription-drug-revenue-projection. Accessed 5 July 2014.
49. Nissen L. Pharmacist Prescribing: What are the next steps. Am J Health Syst Pharm. 2011;68:57-61.
50. Jorgenson D, Lamb D. Practice change challenges and priorities: A national survey of practicing pharmacists. Can Pharm J. 2007;144:125-31.
51. The Translator. http://www.pharmacists.ca/cpha-ca/assets/File/education-practice-resources/Translator2012V6-1EN.pdf. Accessed 20 July 2015.
52. Savage A. The professions in theory and history: The case of Pharmacy. Bus Econ Hist. 1994;23(2):130-60.
53. Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M, Gerard K, et al. Evaluation of nurse and pharmacist independent prescribing: University of Southampton; Keele University. 2010.
54. Tonna A. An international overview of some pharmacist prescribing models. J Malta College Pharm. 2008;14:20-6.
55. Emmerton L, Marriot J. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8(2):217-25.
56. Morgan J, Morgan D, Wright D, Chrystyn H, George B, Booth A, et al. Development, implementation and cost-effectiveness of a protocol for review of combination diuretic prescribing. Br J Clin Pharmacol. 2003;55(3):317-20.
57. Patient Group Direction for the Administration of Hepatitis B vaccine. NHS England. 2012. http://www.barnsleyccg.nhs.uk/CCG%20Downloads/Members/Medicines%20management/Patient%20Group%20Directions/Hepatitis%20B%20v.f.%2025.6.14.pdf. Accessed 8 September 2015.
58. Medication Guide: 2014. Florida Blue. 2014. http://www.bcbsfl.com/. Accessed 20 January 2015.
59. Bhanbhro S, Drennan VM, Grant R, Harris R. Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature. BMC Health Serv Res. 2011;11(1):330.
60. Courtenay M. An overview of non-medical prescribers across one strategic health authority- a questionnaire survey. BMC Health Serv Res. 2012;12:138-51.
61. The Israeli Pharmacists' Union. http://www.pharmacy.org.il/. Accessed 21 January 2014.
62. Berry D. Attitudes towards, and information needs in relation to, supplementary nurse prescribing in the UK: an empirical study. J Clin Nurs. 2006;15:22-8.
63. NPC. www.npc.co.uk. Accessed 18 July 2014.
64. Schindel TJ, Given L. 'Collaboration' is the New Black: Independent Pharmacist Prescribing in a Collaborative Environment. In: Proceedings of the Annual Conference of CAIS/Actes du congrès annuel de l'ACSI. June 2014.
65. A tale of two countries: The path to pharmacist prescribing in the United Kingdom and Canada. American Pharmacist Association. 2014. http://www.pharmacist.com/tale-two-countries-path-pharmacist-prescribing-united-kingdom-and-canada. Accessed 18 July 2014.
66. Israel's elderly facts and figures 2011. Myers -JDC- Brookdale Institute. http://brookdale.jdc.org.il/_Uploads/dbsAttachedFiles/FactsFiguresElderly-ENGLISH-2011.pdf. Accessed 8 September 2015.
67. Inadequate healthcare and general inequity in the periphery Israeli Medical Association. http://www.ima.org.il/ENG/ViewCategory.aspx?CategoryId=6177. Accessed 8 September 2015.
68. The National Health Service (Amendments Relating to Prescribing by Nurses and Pharmacists etc.) (England) Regulations 2003. The UK department of health. http://www.opsi.gov.uk/si/si2003/20030699.htm. Accessed 18 July 2014.
69. University of Southampton. Strong support for nurse and pharmacist prescribing found in UK study. ScienceDaily. 2011. www.sciencedaily.com/releases/2011/05/110510074629.htm. Retrieved January 19, 2015.
70. Canadian Pharmacist Association. www.pharmacists.ca. Accessed 2 January 2014.
71. Weiss MC, Sutton J. The changing nature of prescribing: pharmacists as prescribers and challenges to medical dominance. Sociol Health Illn. 2009;31(3):406-21.
72. Even D. More nurses to be trained to take on doctors' duties, Health Ministry plans. Ha'aretz Digital Edition. December 6, 2012. Accessed 21 January 2014.
73. Knesset protocols 3/3/2014. Knesset Website. www.knesset.gov.il/protocols/data/rtf/avoda/2014-03-03.rtf. Accessed 8 June, 2014.
74. Mizrahi S, Vigoda-Gadot E, Cohen N. Trust, participation and performance in public administration: an empirical examination of health services in Israel. Public Performance Manage Rev. 2009;33(1):7-11.
75. Sax P. The shaping of pharmaceutical governance: the Israeli Case. Isr J Health Policy Res. 2014;3:16.
76. Chernichovsky D, Eitan R. Trends in Israel's healthcare system. State of the Nation Report - Society, Economy and Policy. 2013:1-28.
77. Gross R, Brammli-Greenberg S, Mazliach R. Public opinion on health care Quality of service in the first decade of NHI (In Hebrew). 2005. http://brookdaleheb.jdc.org.il/_Uploads/PublicationsFiles/487rr-pubopin-ES-heb.pdf. Accessed 17 March 2014.
78. The Marker. http://www.themarker.com/consumer/health/1.1870113. Accessed 29 July 2015.
79. Tonna T, Stewart D, West B, McCaig D. Exploring pharmacists' perceptions of the feasibility and value of pharmacist prescribing of antimicrobials in secondary care in Scotland. Int J Pharm Pract. 2010;18:312-9.
80. Makowsky M, Guirguis L, Hughes C, Sadowski C, Yuksel N. Factors influencing pharmacists' adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci. 2013;8:109.
81. OECD. Society at a Glance 2014: OECD Social Indicators. OECD Publishing: 2014. http://dx.doi.org/10.1787/soc_glance-2014-en. Accessed 12 July 2014.
82. OECD. Health at a Glance 2011, OECD Indicators. 2011. http://www.oecd.org/els/health-systems/49105858.pdf. Accessed 12 July 2014.
83. Gross R, Greenstein M, Mazliach R, Tavenkin H, Porat A, Heiman A, et al. Implementing clinical guidelines in primary care medicine in Israel: Changing physicians behaviour. Myers-JDC-Brookdale. 2005. http://brookdale.jdc.org.il/_Uploads/PublicationsFiles/450rr-clinicalguidelines-heb.pdf. Accessed 14 January 2015.
84. Chernichovski D. The health care system. Taub Center. 2014. http://taubcenter.org.il/tauborgilwp/wp-content/uploads/E2009_Report_Healthcare_System_Chapter.pdf. Accessed 6 August 2014
85. Tackling inequalities in health and health care in Israel: OECD Review of Health Care quality in Israel. OECD. http://www.health.gov.il/UnitsOffice/HRS/economy/conventions/Documents/26112012_2.pdf. Accessed 17 March 2014.
86. Mendlovic J, Gordon ES, Haklai Z. Chapter 9 Israel: Geographic Variations in Health Care: What do we know and what can be done to improve health system performance? OECD. http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/geographic-variations-in-health-care/israel-geographic-variations-in-health-care_9789264216594-12-ennopage1. Accessed 4 August 2014.
87. Pharmaline. http://www.pharmaline.co.il/154145. Accessed 2 January 2015.
88. Israel Ministry of Health. Physicians Ordinance 1976. Laws in Israel p. 594: 1976. http://www.nevo.co.il/law_html/Law01/p208_001.htm. Accessed 4 January 2015.
89. The Israeli Medical Association. www.IMA.org.il/eng/viewcategory.aspx?categoryId=4481. Accessed 4 January 2015.
90. Knesset Website - Lexicon of Terms: The Arrangements Law. https://www.knesset.gov.il/lexicon/eng/hesderim_eng.htm Accessed 4 June, 2013.
91. Israel Ministry of Justice. http://www.justice.gov.il/MOJEng/ILITA/About.htm. Accessed 16 August 2014.
92. Israel Ministry of Health. Physicians Ordinance 1976. Pharmacist Ordinance 1976. http://main.knesset.gov.il/Activity/committees/Labor/RegulationApproved/health100314.pdf. Accessed 17 August 2014.
93. Course descriptions. School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem: 2014. https://medicine.ekmd.huji.ac.il. Accessed 15 January 2015.
94. MedNet. www.mednet.co.il. Accessed 17 August 2014.
95. Milken Institute. Israel's health IT industry. http://www.slideshare.net/talor/healthcare-it-in-israel-3520367. Accessed 08 Aug 2015.
96. Mesler MA. Boundary encroachment and task delegation: clinical pharmacists on the medical team. Sociol Health Illness. 1991;13:310-31.
97. Geyer N. Enabling legislation in diagnosis and prescribing of medicine by nurses/health practitioners. Curationis. 2001;24(4):17-24.
98. Medicines and related substances control amendment act. 1997. http://www.chr.up.ac.za/undp/domestic/docs/legislation_54.pdf. Accessed 8 September 2015.
99. Dorward A, Kydd J, Morrison J, Poulton C. Institutions, Markets and Economic Co-ordination: Linking Development Policy to Theory and Praxis. Dev Change. 2005;36(1):1-25.
100. Boggess JE. How can pharmacies improve access to emergency contraception? Perspect Sex Reprod Health. 2002;162-165.